STOCKS TELEGRAPH

Tag: XSPA

  • Q4 Record Financial Results: XpresSpa Group, Inc. (XSPA) Stock Gradually Gaining Pace After Hours.

    Q4 Record Financial Results: XpresSpa Group, Inc. (XSPA) Stock Gradually Gaining Pace After Hours.

    XpresSpa Group, Inc. (XSPA) is an international leader in providing health and wellness services having three distinct brands: XpresCheck, XpresSpa, and Treat. The services provided by the company’s brands include providing on-site (airport) Covid-19 screening and testing, spa services at the airport, and on-demand healthcare access via technology.

    XSPA stock price during the regular trading of March 15, 2022, roared by 7.7% to be $1.06. Its price further soared by 2.83% at the time of writing in the aftermarket session.

    XSPA: Key Financials

    On March 15, 2022, XSPA released its unaudited Q4 2021 financials for the quarter ended December 31, 2021. Some key updates are as follows.

    Revenue

    Total revenue was $29.4 million in Q4 2021 corresponding to $0.3 million in the corresponding quarter of 2020. Its revenue increased phenomenally by $29.1 million YoY.

    EPS

    Basic and diluted net income per share in Q4 2021 was $1.83 million or $0.03 in comparison to a net loss of $16.3 million or $0.22 in the corresponding period of 2020. The company’s EPS increased manifold yearly.

    XSPA: Events and Happenings

    On March 07, 2022, XSPA informed the press about the participation of Scott Milford, its CEO at the Fireside Chat Series of Water Tower Research on March 9, 2022. On February 22, 2022, XSPA announced the inauguration of a second testing facility for COVID-19 by its brand XpresCheck at Denver International Airport.

    On January 31, 2022, XSPA reported along with the Centers for Disease Control and Prevention about the expansion of their preliminary $2 million biosurveillance facility. XpresCheck is providing biosurveillance services at the airports and the total worth of the agreement is $5.6 million.

    Conclusion

    XSPA stock is up to 47% bearish year-to-date mainly as an outcome of the pandemic constraints. Currently, its stock is showing a slight bullish behavior as the company reported record growth in its revenue over the year, along with a significant increase in EPS. For the first quarter of fiscal 2022, the company’s revenue expectations are $27.1 million versus earnings of $0.06 per share.

  • XpresSpa Group Inc. (XSPA) stock declines during pre-market trading session. Let’s find out why?

    XpresSpa Group Inc. (XSPA) stock declines during pre-market trading session. Let’s find out why?

    XpresSpa Group Inc. (XSPA) stock surged by 6.36% in the last trading closed whereas the XSPA stock declines by 13.59% in the pre-market trading after XSPA announced its fourth quarter 2020 financial results. The XpresSpa Group is a multinational health and wellness business. With 45 outlets in 23 airports around the world, the XpresSpa Group’s core asset, XpresSpa, is a leading airport seller of spa services and related health and wellness products.

    Fourth Quarter Financial Results

    • For the fourth quarter 2020 the revenue was $0.3 million relative to $10.9 million for the same time in 2019. The decline in sales was attributed to the negative effects of COVID-19, which resulted in XSPA temporarily closing essentially all global spa locations due to local authorities classifying the spa locations as “non-essential services.”
    • The General and administrative expense was $5.0 million for the fourth quarter of 2020 and 2019, both.
    • XSPA impairment of asset expense relatively increased to $9.0 million from $5.2 million in the previous year.
    • The cash and cash equivalents was calculated as $89.8 million whereas it does not include restricted cash. The total current assets were of $91.8 million and total current liabilities were of $13.5 million.
    • Cost of sales fell to $2.4 million from $9.2 million in the fourth quarter of the previous year. The decrease was attributed to lower variable costs as a result of lower XpresSpa spa sales, as well as a decline in occupancy costs as a result of rent reductions from airports.

    Other Recent Development

    Recently on March 29, 2021, XSPA announced that they will be expanding their COVID-19 testing service through providing travelers with another option with a fast PCR-based testing platform. With the addition, XpresCheck will be able to expand the availability of accelerated PCR–based COVID-19 tests at XpresCheck airport sites, beginning with pilots today at John F. Kennedy International Airport and next week at George Bush Intercontinental Airport in Houston.

    The Accula SARS-CoV-2 Test from Thermo Fisher Scientific will be available via XSPA. The U.S. Food and Drug Administration (FDA) has granted the research procedure an Emergency Use Authorization, and the results are available in 30 minutes.

  • Early Morning Vibes: 4 Top Trending Stocks To Watch Right Now

    Early Morning Vibes: 4 Top Trending Stocks To Watch Right Now

    On March 5, the American stock exchanges closed in the green zone. The S&P 500 rose 1.95% to 3842 points, the Dow Jones added 1.85%, the NASDAQ rose 1.55%. All sectors, led by the energy sector, showed a confident growth, which continues to rally supported by oil prices. After the OPEC + decision to leave the production level unchanged, the energy quotes are moving up. Treasury yields were held near weekly highs. The Fed has confirmed its long-term plans to maintain the current parameters of monetary policy.

    Company News

    Online real estate marketplace CoStar Group (CSGP: + 5.3%) abandoned the acquisition of CoreLogic (CLGX) due to the impact of rising rates on the prospects for the mortgage refinancing market.

    Apparel retailer Gap (GPS: + 7.6%) posted a decline in revenue, but EPS was above forecast. The prospects for the development of the Old Navy and Athleta brands are noted.

    Insurance company Guidewire Software (GWRE: -4.8%) did better than expected, but margins are worrisome.

    Today, global stock markets are showing mixed dynamics. On Saturday, the Senate passed a $ 1.9 trillion stimulus package. It includes a reduction in weekly unemployment benefits from $ 400 to $ 300, direct payments of $ 1,400 for about 85% of American families, $ 350 billion in state and local government assistance, as well as funding a vaccination campaign and expanding tax credits for children. On March 9, a vote on the package will be held in the House of Representatives, after which the law will be submitted to the President for signature. Market participants are confident that the law will be adopted in the first half of March.

    The labor market statistics released on Friday pleasantly surprised investors. The unemployment rate fell to 6.2%, and the leisure and hospitality industry became a driver of new job growth. Against the background of a decrease in the incidence of COVID-19 and active vaccination, some states have eased quarantine restrictions: the mandatory wearing of masks and the observance of social distance in public places have been canceled. This revitalized tourism and recreation, but heightened the risk of the spread of the coronavirus. To date, about 17% of the US population has received the vaccine, and this is not enough to stop the epidemic.

    Uncertain appetite for risk. The 10-year Treasury rate hovers around the 1.55% mark. Brent oil futures rise to $ 70. Gold dropped to $ 1698.

    Technically, the S&P 500 marked a short-term downtrend, maintaining medium-term positive momentum. The broad market index found support near 3700, below the long-term uptrend. In the medium term, mixed dynamics is expected with the nearest support zone of 3640-3700 points.

    Today Top Movers


    Net Element Inc. (NASDAQ: NETE) shares are trading up 22.27% at $10.87 at the time of writing. Mullen Technologies, Inc. which previously announced a definitive agreement to merge with Net Element in a stock-for-stock reverse merger in which Mullen’s stock holders will receive a majority of the outstanding stock in the post-merger company, revealed today a strategic partnership with NexTech Batteries Inc. as an EV battery supplier and key partner for battery development and technologies.

    Anchiano Therapeutics Ltd. (ANCN) stock soared 109.58% to $7.0 in the pre-market trading. 

    Adaptive Biotechnologies Corporation (ADPT), a Biotechnology company, rose about 11.3% at $47.0 in pre-market trading Monday. The company recently declared that the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for T-Detect™ COVID to confirm recent or prior COVID-19 infection. 

    XpresSpa Group Inc. (XSPA) grew over 26.54% at $2.05 in pre-market trading today. On March 4, 2002, the XpresSpa Group,Inc. (Nasdaq: XSPA) announced it has signed a contract with the Port of Seattle for a COVID-19 popup testing facility at at Seattle-Tacoma International Airport (SEA).

    Top Upgrades & Downgrades


    KeyBanc turned bullish on The Trade Desk Inc. (TTD), upgrading the stock to “Overweight” and assigning an $851.0 price target, representing a potential upside of 30.09% from Friday’s close. 

    IQVIA Holdings Inc. (IQV) has won the favor of KeyBanc’s equity research team. The firm upgraded the shares from Sector Weight to Overweight and moved their price target to $218.0, suggesting a 15.61% additional upside for the stock. 

    The Coca-Cola Company (KO) received an upgrade from analysts at RBC Capital, who also set their one-year price target on the stock to $60.0. They changed their rating on KO to Outperform from Sector Perform in a recently issued research note. 

    Earlier Monday KeyBanc reduced its rating on PRA Health Sciences Inc. (PRAH) stock to Sector Weight from Overweight. 

    KeyBanc analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Entergy Corporation (ETR) has been changed to Sector Weight from Overweight. 

    Analysts at Goldman Sachs downgraded Viatris Inc. (VTRS)’s stock to Neutral from Buy Monday.

    Latest Insider Activity


    Freeport-McMoRan Inc. (FCX) Director FORD GERALD J announced the sale of shares taking place on Mar 04 at $33.24 for some 300,000 shares. The total came to more than $9.97 million. 

    Zynga Inc. (ZNGA) Director DUGAN REGINA E sold on Mar 04 a total of 214,588 shares at $10.53 on average. The insider’s sale generated proceeds of almost $94244.0. 

    Cleveland-Cliffs Inc. (CLF) EVP, Chief Financial Officer Koci Keith declared the purchase of shares taking place on Mar 05 at $13.45 for some 15,000 shares. The transaction amount was around $0.2 million. 

    Enterprise Products Partners L.P. (EPD) Director WILLIAMS RANDA DUNCAN bought on Mar 04 a total of 4,915,183 shares at $22.90 on average. The purchase cost the insider an estimated $6.96 million.

    Important Earnings

    Top US earnings releases scheduled for today include Waitr Holdings Inc. (NASDAQ:WTRH). It will announce its Dec 2020 financial results. The company is expected to report earnings of $0.04 per share from revenues of $51.36M in the three-month period. 

    Analysts expect ContextLogic Inc. (NASDAQ:WISH) to report a net income (adjusted) of -$3.03 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $736.11M. 

    CarParts.com Inc. (PRTS), due to announce earnings after the market closes today, is expected to report earnings of -$0.1 per share from revenues of $91.97M recently concluded three-month period.

  • What changed for these 31 stocks in Pre Market Session

    What changed for these 31 stocks in Pre Market Session

    Xenetic Biosciences Inc. (XBIO) stock plunged -15.46% to $2.68 in the pre-market trading following the company’s announcement of $6.0 million registered direct offering priced at-the-market under Nasdaq Rules. The most recent rating by Maxim Group, on January 08, 2020, is a Buy.
    Curis Inc. (CRIS), a Biotechnology company, dropped about -5.72% at $7.25 in pre-market trading Thursday after declaring the pricing of an underwritten public offering of 25,652,174 shares of its common stock at a public offering price of $5.75 per share for total gross proceeds of approximately $147.5 million.
    ZW Data Action Technologies Inc. (CNET) lost over -11.33% at $1.8 in pre-market trading Thursday December 10, 2020 after reporting the official opening of its first live streaming platform in Guangzhou, China.
    Genius Brands International Inc. (GNUS) is up more than 9.74% at $1.69 in pre-market hours Thursday December 10, 2020. The firm recently revealed that it will be presenting at the 13th Annual LD Micro investor conference on Tuesday, December 15th at 10:00 a.m. PST / 1:00 p.m. EST. The stock had dropped over -4.35% to $1.54 in the last trading session.
    Rocket Companies Inc. (RKT), a Mortgage Finance company, rose about 3.09% at $21.71 in pre-market trading Thursday following the release of Clear HOI platform from its subsidiary to mortgage lenders nationwide.
    Intec Pharma Ltd (NTEC) stock moved down -7.76 percent to $4.28 in the pre-market trading. Intec Pharma Announces Cannabinoid Research Collaboration with GW Pharma.
    Atossa Therapeutics Inc. (ATOS) gained over 2.31% at $0.8919 in pre-market trading Thursday December 10, 2020 after revealing cannabinoid research collaboration with GW Pharma.
    Nano Dimension Ltd. (NNDM) is up more than 2.25% at $6.82 in pre-market hours Thursday December 10, 2020 following the declaration from the company that it has closed the registered direct offering of 30,000,000 of the Company’s American Depositary Shares at a price of $6.00 per ADS. The stock had dropped over -6.06% to $6.67 in the last trading session.
    Before the trading started on December 10, 2020, Sorrento Therapeutics Inc. (SRNE) is down -2.44% to reach $8.01 following the FDA acceptance of its Investigational New Drug (IND) application for its Phase 1 clinical trials for intravenous (IV) STI-2020 (COVI-AMG). It has been trading in a 52-week range of $1.55 to $19.39.
    Genetic Technologies Limited (GENE) stock plunged -9.17% to $4.06 in the pre-market trading.
    Greenwich LifeSciences Inc. (GLSI) grew over 46.76% at $83.8 in pre-market trading today after reporting the publication of a poster for the GP2 Phase IIb clinical trial final efficacy analysis at the San Antonio Breast Cancer Symposium in a virtual format.
    Lipocine Inc. (LPCN), a Biotechnology company, dropped about -5.3% at $1.25 in pre-market trading Thursday after announcing that the U.S. Food and Drug Administration has granted tentative approval to TLANDO.
    SELLAS Life Sciences Group Inc. (SLS) stock moved up 51.8 percent to $9.7 in the pre-market trading. The biotechnology firm recently revealed exclusive license agreement with 3D Medicines for development and commercialization of Galinpepimut-S (GPS) and GPS+ in Greater China.
    Francesca’s Holdings Corporation (NASDAQ: FRAN) shares are trading down -10.68% at $2.51 at the time of writing after receiving court approval of “First Day” motions to support ongoing operations. Company’s 52-week ranged between $1.70 to $19.91. Analysts have a consensus price target of $2.50.
    Oncternal Therapeutics Inc. (ONCT) tumbled over -27.78% at $4.55 in pre-market trading today after announcing that the firm increased its previously declared bought deal to $75.0 million.
    Gran Tierra Energy Inc. (GTE) is down more than -2.83% at $0.35 in pre-market hours Thursday December 10, 2020. The company recently declared a financial update and the Company’s 2021 capital budget and production guidance. The stock had dropped over -5.68% to $0.36 in the last trading session.
    Before the trading started on December 10, 2020, Fisker Inc. (FSR) is down -4.04% to reach $16.15. The firm recently confirmed that it has signed agreements with Cox Automotive U.K. (“Cox”) and Rivus Fleet Solutions for delivery, servicing, fleet management and reselling programs in the United Kingdom. It has been trading in a 52-week range of $8.70 to $23.63.
    Immutep Limited (IMMP) stock soared 89.35% to $4.09 in the pre-market trading after declaring that its Chinese partner, EOC Pharma will commence a new Phase II clinical trial in up to 152 metastatic breast cancer patients in China. The most recent rating by B. Riley FBR, on September 28, 2018, is a Buy.
    Remark Holdings Inc. (MARK), a Internet Content & Information company, rose about 3.09% at $1.67 in pre-market trading Thursday after reporting that Remark’s KanKan AI business successfully released its edge computing systems, the S and T Series Smart Boxes.
    Baidu Inc. (BIDU) gained over 2.42% at $155.26 in pre-market trading Thursday December 10, 2020. The firm recently released new intelligent vehicle solutions for automakers and several high-end intelligent driving products during the second Apollo Ecosystem Conference.
    Before the trading started on December 10, 2020, Editas Medicine Inc. (EDIT) is up 9.13% to reach $55.2 after reporting submission of IND application for EDIT-301 with the FDA. It has been trading in a 52-week range of $14.01 to $43.65.
    Artelo Biosciences Inc. (ARTL) stock plunged -2.47% to $0.66 in the pre-market trading. The healthcare firm recently declared that it has filed a composition of matter patent application directed to a new solid dosage formulation, including its method of use, with the UK Patent Office.
    AquaBounty Technologies Inc. (NASDAQ: AQB) shares are trading down -17.07% at $7.19 at the time of writing following the selection of Innovasea as the Recirculating Aquaculture Systems (“RAS”) technology provider for its planned 10,000 metric ton farm. Company’s 52-week ranged between $1.52 to $11.40. Analysts have a consensus price target of $5.
    Pluristem Therapeutics Inc. (PSTI) lost over -5.57% at $6.61 in pre-market trading Thursday December 10, 2020 after declaring DMC recommendation following interim analysis of its phase III CLI study.
    Before the trading started on December 10, 2020, Veru Inc. (VERU) is up 25.96% to reach $4.9 after reporting that it has exclusively licensed worldwide rights to enobosarm, a late-stage oral novel androgen receptor (AR) targeting agent for the treatment of endocrine resistant ER+ HER2- metastatic breast cancer. It has been trading in a 52-week range of $2.10 to $4.74.
    Uranium Energy Corp. (AMEX: UEC) shares are trading down -4.32% at $1.33 at the time of writing. Company’s 52-week ranged between $0.35 to $1.59. Analysts have a consensus price target of $1.50.
    Boxlight Corporation (BOXL), a Communication Equipment company, rose about 7.23% at $1.78 in pre-market trading Thursday. The firm recently confirmed that they are the recipients of three THE Journal’s Best New EdTech Product Awards.
    Regulus Therapeutics Inc. (RGLS) stock moved up 19.34 percent to $1.07 in the pre-market trading. The company lately announced closing of $19.4 million private placement of equity.
    Before the trading started on December 10, 2020, Sea Limited (SE) is down -3.3% to reach $196.0 after reporting that it proposes to offer 11,000,000 American Depositary Shares, each representing one Class A ordinary share of the Company, in an underwritten public offering. It has been trading in a 52-week range of $35.61 to $207.51.
    Barclays PLC (NYSE: BCS) shares are trading down -3.85% at $7.5 at the time of writing. The firm recently revealed the launch of BARX Book for Equities, a new single-dealer platform developed in partnership with Nasdaq (Nasdaq: NDAQ). Company’s 52-week ranged between $3.41 to $10.22.
    Qualigen Therapeutics Inc. (QLGN) stock moved up 13.85 percent to $4.44 in the pre-market trading. The company recently announced board member Amy Broidrick as EVP, Chief Strategy Officer and named Sidney Emery, Jr. to its board.